360 related articles for article (PubMed ID: 29592953)
41. Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study.
Wisinski KB; Xu W; Tevaarwerk AJ; Saha S; Kim K; Traynor A; Dietrich L; Hegeman R; Patel D; Blank J; Harter J; Burkard ME
Clin Breast Cancer; 2016 Aug; 16(4):256-61. PubMed ID: 27133732
[TBL] [Abstract][Full Text] [Related]
42. [10]-Gingerol Affects Multiple Metastatic Processes and Induces Apoptosis in MDAMB- 231 Breast Tumor Cells.
Fuzer AM; Martin ACBM; Becceneri AB; da Silva JA; Vieira PC; Cominetti MR
Anticancer Agents Med Chem; 2019; 19(5):645-654. PubMed ID: 30370858
[TBL] [Abstract][Full Text] [Related]
43. Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.
Erin N; Podnos A; Tanriover G; Duymuş Ö; Cote E; Khatri I; Gorczynski RM
Oncogene; 2015 Jul; 34(29):3860-70. PubMed ID: 25263452
[TBL] [Abstract][Full Text] [Related]
44. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
45. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
46. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis.
Carmi Y; Rinott G; Dotan S; Elkabets M; Rider P; Voronov E; Apte RN
J Immunol; 2011 Mar; 186(6):3462-71. PubMed ID: 21300825
[TBL] [Abstract][Full Text] [Related]
47. Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis.
Kang T; Zhu Q; Wei D; Feng J; Yao J; Jiang T; Song Q; Wei X; Chen H; Gao X; Chen J
ACS Nano; 2017 Feb; 11(2):1397-1411. PubMed ID: 28075552
[TBL] [Abstract][Full Text] [Related]
48. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
49. Treating metastatic triple negative breast cancer with CD44/neuropilin dual molecular targets of multifunctional nanoparticles.
Liang DS; Zhang WJ; Wang AT; Su HT; Zhong HJ; Qi XR
Biomaterials; 2017 Aug; 137():23-36. PubMed ID: 28528300
[TBL] [Abstract][Full Text] [Related]
50. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity.
Ikutani M; Yanagibashi T; Ogasawara M; Tsuneyama K; Yamamoto S; Hattori Y; Kouro T; Itakura A; Nagai Y; Takaki S; Takatsu K
J Immunol; 2012 Jan; 188(2):703-13. PubMed ID: 22174445
[TBL] [Abstract][Full Text] [Related]
51. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
[TBL] [Abstract][Full Text] [Related]
52. ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis.
Reese JM; Bruinsma ES; Nelson AW; Chernukhin I; Carroll JS; Li Y; Subramaniam M; Suman VJ; Negron V; Monroe DG; Ingle JN; Goetz MP; Hawse JR
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9580-E9589. PubMed ID: 30257941
[TBL] [Abstract][Full Text] [Related]
53. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
[TBL] [Abstract][Full Text] [Related]
54. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
55. Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.
Yakimchuk K; Iravani M; Hasni MS; Rhönnstad P; Nilsson S; Jondal M; Okret S
Leukemia; 2011 Jul; 25(7):1103-10. PubMed ID: 21502954
[TBL] [Abstract][Full Text] [Related]
56. Estrogen induces lung metastasis through a host compartment-specific response.
Banka CL; Lund CV; Nguyen MT; Pakchoian AJ; Mueller BM; Eliceiri BP
Cancer Res; 2006 Apr; 66(7):3667-72. PubMed ID: 16585192
[TBL] [Abstract][Full Text] [Related]
57. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
[TBL] [Abstract][Full Text] [Related]
58. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells.
Hodges-Gallagher L; Valentine CD; El Bader S; Kushner PJ
Breast Cancer Res Treat; 2008 May; 109(2):241-50. PubMed ID: 17638070
[TBL] [Abstract][Full Text] [Related]
59. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
[TBL] [Abstract][Full Text] [Related]
60. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
